First Time Loading...
E

Enhabit Inc
NYSE:EHAB

Watchlist Manager
Enhabit Inc
NYSE:EHAB
Watchlist
Price: 8.34 USD 0.6% Market Closed
Updated: May 11, 2024
Section:
 

Relative Value

The Relative Value of one EHAB stock under the Base Case scenario is 26.27 USD. Compared to the current market price of 8.34 USD, Enhabit Inc is Undervalued by 68%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EHAB Relative Value
Base Case
26.27 USD
Undervaluation 68%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
88
vs Industry
82
Median 3Y
0.6
Median 5Y
0.6
Industry
2.4
Forward
0.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
43
Median 3Y
-4.3
Median 5Y
-4.3
Industry
23.9
Forward
33.2
More Details
8.6
P/OCF
P/OCF
Price to OCF
8.6
vs History
64
vs Industry
39
Median 3Y
9.3
Median 5Y
9.3
Industry
15.6
More Details
36.4
P/FCFE
P/FCFE
Price to FCFE
36.4
vs History
19
vs Industry
17
Median 3Y
1.1
Median 5Y
1.1
Industry
22.5
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
88
vs Industry
74
Median 3Y
0.8
Median 5Y
0.8
Industry
2.3
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
88
vs Industry
71
Median 3Y
1.1
Median 5Y
1.1
Industry
2.5
Forward
0.8
More Details
1.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.8
vs History
88
vs Industry
72
Median 3Y
2.1
Median 5Y
2.1
Industry
5.3
More Details
13.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.3
vs History
19
vs Industry
27
Median 3Y
10.1
Median 5Y
10.1
Industry
12.9
Forward
9.1
More Details
24.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.1
vs History
19
vs Industry
20
Median 3Y
13.4
Median 5Y
13.4
Industry
17.8
Forward
13.8
More Details
19
EV/OCF
EV/OCF
Enterprise Value to OCF
19
vs History
40
vs Industry
24
Median 3Y
17.5
Median 5Y
17.5
Industry
15.4
More Details
20.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.5
vs History
68
vs Industry
24
Median 3Y
23.8
Median 5Y
23.8
Industry
19.6
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
88
vs Industry
71
Median 3Y
0.8
Median 5Y
0.8
Industry
2
More Details

Multiples Across Competitors

EHAB Competitors Multiples
Enhabit Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Enhabit Inc
NYSE:EHAB
418.1m USD 0.4 -5.2 13.3 24.1
US
Cigna Group
XMUN:CGN
92.4B EUR 0.5 27.5 9.9 13.1
US
Cigna Corp
NYSE:CI
99B USD 0.5 27.4 9.8 13
US
CVS Health Corp
NYSE:CVS
69.9B USD 0.2 9.5 8.6 8.6
US
Laboratory Corporation of America Holdings
NYSE:LH
17.5B USD 1.4 40.4 12.2 18.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR 0.7 -27.2 10.2 22.9
US
Quest Diagnostics Inc
NYSE:DGX
15.4B USD 1.7 18.2 10.9 14.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.9B EUR 0.6 23.8 7 16.5
DE
Fresenius Medical Care AG
XMUN:FME
11.4B EUR 0.6 22.8 6.8 16.2
US
DaVita Inc
NYSE:DVA
12.1B USD 1 14.8 8.3 11.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
EHAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
EHAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EHAB stock valuation using valuation multiples.
Wall Street Estimates
EHAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EHAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.